Boston Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-861
| Closed | -$204K | – | 636 |
|
|
2019
Q1 | $204K | Sell |
861
-230
| -21% | -$54.5K | 0.01% | 615 |
|
|
2018
Q4 | $328K | Buy |
1,091
+31
| +3% | +$9.32K | 0.02% | 519 |
|
|
2018
Q3 | $375K | Sell |
1,060
-590
| -36% | -$209K | 0.02% | 523 |
|
|
2018
Q2 | $479K | Sell |
1,650
-1,226
| -43% | -$356K | 0.01% | 497 |
|
|
2018
Q1 | $788K | Buy |
2,876
+11
| +0.4% | +$3.01K | 0.02% | 414 |
|
|
2017
Q4 | $913K | Sell |
2,865
-6
| -0.2% | -$1.91K | 0.02% | 378 |
|
|
2017
Q3 | $899K | Buy |
2,871
+427
| +17% | +$134K | 0.02% | 374 |
|
|
2017
Q2 | $663K | Sell |
2,444
-2,913
| -54% | -$790K | 0.02% | 434 |
|
|
2017
Q1 | $1.47M | Sell |
5,357
-102,956
| -95% | -$28.2M | 0.03% | 309 |
|
|
2016
Q4 | $30.7M | Sell |
108,313
-279
| -0.3% | -$79.1K | 0.74% | 22 |
|
|
2016
Q3 | $34M | Sell |
108,592
-18,755
| -15% | -$5.87M | 0.84% | 21 |
|
|
2016
Q2 | $30.8M | Buy |
127,347
+121,866
| +2,223% | +$29.5M | 0.77% | 26 |
|
|
2016
Q1 | $1.43M | Sell |
5,481
-1,475
| -21% | -$384K | 0.04% | 282 |
|
|
2015
Q4 | $2.13M | Sell |
6,956
-880
| -11% | -$270K | 0.05% | 257 |
|
|
2015
Q3 | $2.29M | Sell |
7,836
-20,060
| -72% | -$5.85M | 0.09% | 256 |
|
|
2015
Q2 | $11.3M | Sell |
27,896
-605
| -2% | -$244K | 0.47% | 64 |
|
|
2015
Q1 | $12M | Buy |
28,501
+1,470
| +5% | +$621K | 0.48% | 68 |
|
|
2014
Q4 | $9.18M | Sell |
27,031
-1,870
| -6% | -$635K | 0.39% | 85 |
|
|
2014
Q3 | $9.56M | Buy |
28,901
+22,835
| +376% | +$7.55M | 0.41% | 84 |
|
|
2014
Q2 | $1.91M | Hold |
6,066
| – | – | 0.08% | 217 |
|
|
2014
Q1 | $1.86M | Buy |
6,066
+89
| +1% | +$27.2K | 0.08% | 217 |
|
|
2013
Q4 | $1.67M | Sell |
5,977
-75
| -1% | -$21K | 0.08% | 213 |
|
|
2013
Q3 | $1.46M | Sell |
6,052
-3,164
| -34% | -$762K | 0.08% | 214 |
|
|
2013
Q2 | $1.98M | Buy |
+9,216
| New | +$1.98M | 0.1% | 180 |
|